The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia

• Main Authors: Eissa, H.M, Zhou, Y, Panetta, J.C, Browne, E.K, Jeha, S, Cheng, C, Relling, M.V, Campana, D, Pui, C.-H, Inaba, H
• Other Authors: PAEDIATRICS
• Format: Article
• Published: Nature Publishing Group 2020
• Subjects: asparaginase; cyclophosphamide; cytarabine; daunorubicin; mercaptopurine; methotrexate; prednisone; vincristine; acute lymphoblastic leukemia; age; Article; body mass; bone marrow cancer; cancer combination chemotherapy; cancer diagnosis; cancer incidence; cancer mortality; cancer risk; cancer survival; child; childhood leukemia; childhood obesity; clinical outcome; cohort analysis; consolidation chemotherapy; event free survival; female; human; induction chemotherapy; leukemia relapse; leukemia remission; major clinical study; male; minimal residual disease; overall survival; prospective study; risk assessment; systemic therapy; treatment response; underweight; infant; pathology; Precursor Cell Lymphoblastic Leukemia-Lymphoma; preschool child; treatment outcome; Body Mass Index; Child; Child, Preschool; Female; Humans; Infant; Male; Treatment Outcome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/179749

10.1038/bcj.2017.11